Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
106,31-05-2024,GBAWE,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MELATONIN[ RESTWELL | 6MG | Tablet ]",,,31-05-2024,31-05-2024,,,0,OPD,
257,31-05-2024,AWUTU BEREKU NEAR THE DURBA GROUND,43 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"I10.00 [Essential (primary) hypertension]  ==> OLD, I89.0 [Lymphoedema, not elsewhere classified]  ==> OLD",No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,31-05-2024,31-05-2024,,,115,OPD,
278,31-05-2024,GBAWE,38 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"O24.419 [Gestational diabetes mellitus in pregnancy, unspecified control]  ==> NEW",I10.00 [Essential (primary) hypertension]  ==> NEW,Yes,Insured,,,,,31-05-2024,31-05-2024,,,50,OPD,
304,31-05-2024,WEIJA WATER WORKS,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",caterer,,31-05-2024,31-05-2024,,,0,OPD,
370,31-05-2024,MAMPROBI,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | Daily |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Pensioner,,31-05-2024,31-05-2024,,,0,OPD,
463,31-05-2024,"MALLAM , BEHIND LAFA POLICE STATION ",66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,31-05-2024,31-05-2024,,,0,OPD,
476,31-05-2024,new applaku,60 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ]",,,31-05-2024,31-05-2024,,,0,OPD,
750,31-05-2024,TUBA JUNCTION,56 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ], CALCIUM GLUCONATE INJECTION[ CALCIUM GLUCONATE | 10MG/ML IN 10ML | Injection | OD |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], CALCIUM GLUCONATE INJECTION[ CALCIUM GLUCONATE | 10MG/ML IN 10ML | Injection ]",TRADER,,31-05-2024,31-05-2024,,,155,OPD,
807,30-05-2024,KWASHIEBU,88 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,30-05-2024,30-05-2024,,,10,OPD,7533/16 MR-4A-E6-90
854,30-05-2024,scc red top ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,30-05-2024,30-05-2024,,,0,OPD,
857,30-05-2024,APLUKU,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 0 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,30-05-2024,30-05-2024,,,10,OPD,
858,30-05-2024,Amanfrom,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | OD |  For 7 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ], MELATONIN[ RESTWELL | 6MG | Tablet ]",,,30-05-2024,30-05-2024,,,0,OPD,
860,30-05-2024,mallam top base,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,30-05-2024,30-05-2024,,,10,OPD,
864,30-05-2024,MALLAM ABASE,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,30-05-2024,30-05-2024,,,10,OPD,
866,30-05-2024,Mccarthy down,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]",,,,30-05-2024,30-05-2024,,,10,OPD,
896,30-05-2024,KWASHIEMAN CHRIST MISSION,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,"A01.0 [Typhoid fever]  ==> OLD, E78.4 [Other hyperlipidaemia]  ==> OLD, N18.3 [Chronic kidney disease, stage 3]  ==> NEW",No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LEVOFLOXACIN TABLET 500MG[ LEVOFLOXACIN | 500MG | Tablet | BID |  For 10 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | Daily |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LEVOFLOXACIN TABLET 500MG[ LEVOFLOXACIN | 500MG | Tablet ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ]",TRADER,,30-05-2024,30-05-2024,,,0,OPD,
901,30-05-2024,AMASAMAN ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,30-05-2024,30-05-2024,,,0,OPD,
905,30-05-2024,OBLOGO,50 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Para Professional,,30-05-2024,30-05-2024,,,10,OPD,
923,30-05-2024,DJANMAN ,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.01 [Type 2 diabetes mellitus with hyperosmolarity with coma]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Once |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Once |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], FERROUS ASCORBATE+FOLIC ACID [ FEMOM | 30MG+55OMCG/5ML | Suspension | OD |  For 12 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], FERROUS ASCORBATE+FOLIC ACID [ FEMOM | 30MG+55OMCG/5ML | Suspension ]",pension,,30-05-2024,30-05-2024,,,10,OPD,
1098,30-05-2024,gbawe top base,67 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]",,,,30-05-2024,30-05-2024,,,0,OPD,
1099,30-05-2024,"WEIJA, DJAMAN",60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,30-05-2024,30-05-2024,,,10,OPD,
1209,30-05-2024,old barrier,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ]","PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,30-05-2024,30-05-2024,,,0,OPD,
1214,30-05-2024,mccarthy,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,30-05-2024,30-05-2024,,,50,OPD,
1239,30-05-2024,mallam,60 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,"E08.3212 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye]  ==> NEW",,No,Insured,,,,,30-05-2024,30-05-2024,,,0,OPD,
1291,30-05-2024,TETEGU,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,TRADER,,30-05-2024,30-05-2024,,,50,OPD,
1663,29-05-2024,OBLOGO NEW SITE,61 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ],TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ],TRADER,,29-05-2024,29-05-2024,,,0,OPD,
1720,29-05-2024,keneshie ,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,29-05-2024,29-05-2024,,,10,OPD,
1721,29-05-2024,manteheko,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,29-05-2024,29-05-2024,,,10,OPD,
1724,29-05-2024,odorkor,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",,,29-05-2024,29-05-2024,,,10,OPD,
1762,29-05-2024,TOP BASE,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","MELATONIN[ RESTWELL | 6MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Retired,,29-05-2024,29-05-2024,,,10,OPD,
1834,29-05-2024,"TUBA , KAKRABA",52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,,,TRADER,,29-05-2024,29-05-2024,,,50,OPD,
1904,29-05-2024,"NEW BORTIANOR
FINNEY HOSPITAL",67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,29-05-2024,29-05-2024,,,10,OPD,
2112,29-05-2024,AGAPE UP TWON,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ]",Para Professional,,29-05-2024,29-05-2024,,,0,OPD,
2136,29-05-2024,CHOICE,69 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,29-05-2024,29-05-2024,,,50,OPD,
2445,28-05-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,,,,,28-05-2024,28-05-2024,,,10,OPD,
2519,28-05-2024,Kokrobite,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,28-05-2024,28-05-2024,,,10,OPD,
2531,28-05-2024,gbawe,84 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-05-2024,28-05-2024,,,10,OPD,
2579,28-05-2024,DANSOMAN-BEACH,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-05-2024,28-05-2024,,,10,OPD,
2596,28-05-2024,GBAWE,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | BID |  For 60 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 60 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | BDS |  For 60 Days  ]",,,,28-05-2024,28-05-2024,,,0,OPD,
2645,28-05-2024,new gbawe,75 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,28-05-2024,28-05-2024,,,60,OPD,
2711,28-05-2024,MALLAM JULI KAT,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-05-2024,28-05-2024,,,10,OPD,72965/14  MR-9B-E6-22
2719,28-05-2024,gbawe top base,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Once |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Once |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Once |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | PRN |  For 10 Days  ]",,,,28-05-2024,28-05-2024,,,0,OPD,
2770,28-05-2024,GBAWE ZERO,74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | BDS |  For 90 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ]",,,28-05-2024,28-05-2024,,,10,OPD,
2863,28-05-2024,"GBAWE
BULEMIN",29 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | OD |  For 10 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-05-2024,28-05-2024,,,0,OPD,
2937,28-05-2024,KASOA AKWELEY,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,28-05-2024,28-05-2024,,,10,OPD,
3034,28-05-2024,"DARKUMAN , NEAR AFROPA HOUSE ",52 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-05-2024,28-05-2024,,,0,OPD,
3263,28-05-2024,,64 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,28-05-2024,28-05-2024,,,0,OPD,
3416,27-05-2024,new bortianor,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ]",,,,27-05-2024,27-05-2024,,,10,OPD,
3419,27-05-2024,OBOLOGO,44 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,27-05-2024,27-05-2024,,,0,OPD,
3423,27-05-2024,ANYAA,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,27-05-2024,27-05-2024,,,10,OPD,
3428,27-05-2024,WEIJA ITS,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,27-05-2024,27-05-2024,,,10,OPD,
3430,27-05-2024,galileye,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Once |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-05-2024,27-05-2024,,,10,OPD,
3431,27-05-2024,mallam  government school,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,27-05-2024,27-05-2024,,,10,OPD,
3432,27-05-2024,mallam,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,27-05-2024,27-05-2024,,,10,OPD,
3611,27-05-2024,ABLEKUMA,67 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ]",Retired,,27-05-2024,27-05-2024,,,10,OPD,
3616,27-05-2024,OLD BARRIER ,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | BDS |  For 60 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",,,27-05-2024,27-05-2024,,,10,OPD,
3620,27-05-2024,awoshie,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-05-2024,27-05-2024,,,0,OPD,
3649,27-05-2024,"TUBA
MOUNTAIN VIEW",40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | OD |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,27-05-2024,27-05-2024,,,10,OPD,
3658,27-05-2024,ablekuman,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ]",,,27-05-2024,27-05-2024,,,10,OPD,
3667,27-05-2024,AMERICAN TOWN,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.42 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | OD |  For 10 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ]",,,27-05-2024,27-05-2024,,,0,OPD,
3969,27-05-2024,mccarthy,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-05-2024,27-05-2024,,,0,OPD,
4628,25-05-2024,KASOA-CP,57 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | TID |  For 7 Days  ], LIDOCAINE INJECTION 2%[ LIDOCAINE |   2% 20ML | Injection | Stat |  For 1 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | BDS |  For 1 Days  ], PETHIDINE INJECTION 100MG[ PETHIDINE | 100MG/2ML | Injection | BDS |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], LIDOCAINE INJECTION 2%[ LIDOCAINE |   2% 20ML | Injection ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution ], PETHIDINE INJECTION 100MG[ PETHIDINE | 100MG/2ML | Injection ]",driver,,25-05-2024,25-05-2024,,,65,OPD,
4826,24-05-2024,ABLEKUMA-CURVE,75 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"E78.4 [Other hyperlipidaemia]  ==> OLD, I64.00 [Stroke, not specified as haemorrhage or infarction]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ]",,Unemployed,,24-05-2024,24-05-2024,,,0,OPD,
4894,24-05-2024,"WEIJA , CHOICE ",56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]",,,,24-05-2024,24-05-2024,,,60,OPD,
4929,24-05-2024,SCC 38DELMONT STR,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",Unemployed,,24-05-2024,24-05-2024,,,60,OPD,
5079,24-05-2024,scc behind new vision hotel,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,24-05-2024,24-05-2024,,,10,OPD,
5383,24-05-2024,KASOA NURSE QUATERS,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | Daily |  For 30 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]",,AGED,,24-05-2024,24-05-2024,,,0,OPD,
5562,23-05-2024,AWOSHIE-ANNAMEME,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,N34.2 [Other urethritis]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",TRADER,,23-05-2024,23-05-2024,,,60,OPD,
5612,23-05-2024,weija choice,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,23-05-2024,23-05-2024,,,0,OPD,
5614,23-05-2024,RUSSIA,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 90 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ]",,,23-05-2024,23-05-2024,,,10,OPD,
5661,23-05-2024,Mallam melcom,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,I10 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,23-05-2024,23-05-2024,,,10,OPD,
5662,23-05-2024,SCC,61 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ]",,,,23-05-2024,23-05-2024,,,0,OPD,
5664,23-05-2024,gbawe top base,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,23-05-2024,23-05-2024,,,10,OPD,
5691,23-05-2024,odorkor,55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"N34.2 [Other urethritis]  ==> NEW, M79.1 [Myalgia]  ==> NEW, G62.9 [Polyneuropathy, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], OSTEOCARE TABLET[ OSTEOCARE |  | Tablet | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], OSTEOCARE TABLET[ OSTEOCARE |  | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",TRADER,,23-05-2024,23-05-2024,,,0,OPD,
5959,23-05-2024,ABLEKUMAH-AGAPE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,23-05-2024,23-05-2024,,,10,OPD,
5997,23-05-2024,tetegu,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,23-05-2024,23-05-2024,,,10,OPD,
6016,23-05-2024,tuba,51 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ]",,TRADER,,23-05-2024,23-05-2024,,,10,OPD,
6089,23-05-2024,benjeys mccarthy,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ROSUVASTATIN [ ROSUVASTATIN  | 10MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ROSUVASTATIN [ ROSUVASTATIN  | 10MG | Tablet ]",Unemployed,,23-05-2024,23-05-2024,,,5,OPD,
6314,23-05-2024,WEIJA WATERWORKS,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,23-05-2024,23-05-2024,,,60,OPD,
6366,23-05-2024,ABLEKUMA,47 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | BDS |  For 2 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",GAS MECHANIC,,23-05-2024,23-05-2024,,,155,OPD,
6376,22-05-2024,"SAKAMAN , OPP OSEI KWAME",40 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],FACTORYHAND,,22-05-2024,22-05-2024,,,70,OPD,
6424,22-05-2024,juwulu,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]",,,,22-05-2024,22-05-2024,,,10,OPD,
6452,22-05-2024,new bortianor,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ]",,,,22-05-2024,22-05-2024,,,10,OPD,
6549,22-05-2024,"MALLAM
BORLA TOP",59 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 60 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",driver,,22-05-2024,22-05-2024,,,10,OPD,
6557,22-05-2024,McCarthy hill,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ]",,,22-05-2024,22-05-2024,,,90,OPD,
6563,22-05-2024,tetegu,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,22-05-2024,22-05-2024,,,0,OPD,
6639,22-05-2024,AWOSHIE,39 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,22-05-2024,22-05-2024,,,0,OPD,
6640,22-05-2024,ABLEKUMA OLEBU,57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,22-05-2024,22-05-2024,,,60,OPD,
6656,22-05-2024,WEIJA-MANDELA SCC,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-05-2024,22-05-2024,,,0,OPD,21620/19
7094,22-05-2024,GBAWE GRAVEL JUNCTION,53 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-05-2024,22-05-2024,,,0,OPD,
7235,21-05-2024,KANESHIE,56 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 7 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,21-05-2024,21-05-2024,,,10,OPD,
7271,21-05-2024,tetegu,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ]",,,21-05-2024,21-05-2024,,,0,OPD,
7305,21-05-2024,"AWOSHI,ODORGORNOR",49 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",SECURITY PERSONNEL,,21-05-2024,21-05-2024,,,0,OPD,
7363,21-05-2024,ABLEKUMAN,62 Year(s),Female,EYE CLINIC ,Review Consultation Adult ,,No Outcome,NA ,E13.36 [Other specified diabetes mellitus with diabetic cataract]  ==> NEW,,No,Insured,NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | TID |  For 1 Days  ],,,,21-05-2024,21-05-2024,,,0,OPD,
7387,21-05-2024,"MALLAM
JNC",44 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M79.1 [Myalgia]  ==> NEW",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 14 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",FARMER,,21-05-2024,21-05-2024,,,10,OPD,
7393,21-05-2024,GBEWE TOP BASE ,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]",,,,21-05-2024,21-05-2024,,,10,OPD,
7394,21-05-2024,ASOFA,42 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Stat |  For 1 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], Polygynax (pessaries)[  |  | Pessary ]",,,21-05-2024,21-05-2024,,,10,OPD,
7405,21-05-2024,NEW  BORTIANOR,48 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7407,21-05-2024,KASOA-TOMEFAH,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Pensioner,,21-05-2024,21-05-2024,,,10,OPD,412/16 MR-13A-C2-71
7412,21-05-2024,tetegu,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7413,21-05-2024,AWOSHIE,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7415,21-05-2024,gbawe,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]",,,,21-05-2024,21-05-2024,,,0,OPD,
7416,21-05-2024,kasoa,67 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,21-05-2024,21-05-2024,,,0,OPD,
7478,21-05-2024,WEIJA,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-05-2024,21-05-2024,,,0,OPD,
7485,21-05-2024,NEW BORTIANO,42 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,A09.9 [Gastroenteritis and colitis of unspecified origin]  ==> NEW,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder | TDS |  For 3 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], ZINC TABLET 20MG [ ZINC SULPHATE | 20MG | Tablet | Daily |  For 10 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ZINC TABLET 20MG [ ZINC SULPHATE | 20MG | Tablet ]",,,21-05-2024,21-05-2024,,,0,OPD,
7496,21-05-2024,AKOM,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | Nocte |  For 30 Days  ]",,,,21-05-2024,21-05-2024,,,10,OPD,
7500,21-05-2024,MALLAM ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7513,21-05-2024,"KASOA,ANNOR TOWN",61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ]",,TRADER,,21-05-2024,21-05-2024,,,10,OPD,
7552,21-05-2024,kasoa,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 1 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 0 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7563,21-05-2024,ablekuman,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,21-05-2024,21-05-2024,,,10,OPD,
7816,21-05-2024,ABLEKUMA,47 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-05-2024,21-05-2024,,,15,OPD,
7935,21-05-2024,new bortianor red top,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, N39.0 [Urinary tract infection, site not specified]  ==> RECURRING",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | TDS |  For 14 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",,,21-05-2024,21-05-2024,,,0,OPD,
8080,21-05-2024,NEW BORTINOR-BABA DOGO LAST TOP,74 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Retired,,21-05-2024,21-05-2024,,,95,OPD,
8119,20-05-2024,KASOA AKWELLEY NEWTOWN,60 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.41 [Type 2 diabetes mellitus with diabetic mononeuropathy]  ==> NEW,"D50.9 [Iron deficiency anaemia, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 14 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | Daily |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",Unemployed,,20-05-2024,20-05-2024,,,70,OPD,
8220,20-05-2024,mallam,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,20-05-2024,20-05-2024,,,0,OPD,
8224,20-05-2024,"NEW WEIJA , ROMAN SCHOOL",60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]",,,,20-05-2024,20-05-2024,,,10,OPD,
8230,20-05-2024,awoshie,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | Nocte |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MELATONIN[ RESTWELL | 6MG | Tablet ]",,,20-05-2024,20-05-2024,,,10,OPD,
8234,20-05-2024,KASOA OPEIKUMA,51 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ]",,UNSKILLED LABOURED,,20-05-2024,20-05-2024,,,10,OPD,
8237,20-05-2024,nyamitse,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 5 Days  ]",,,,20-05-2024,20-05-2024,,,10,OPD,
8311,20-05-2024,weija new town,53 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]",,,,20-05-2024,20-05-2024,,,10,OPD,
8401,20-05-2024,KWASHIEMAN CHRIST MISSION,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,20-05-2024,20-05-2024,,,0,OPD,
8446,20-05-2024,ABLEKUMAH-AGAPE,56 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ]",,,20-05-2024,20-05-2024,,,85,OPD,MR-10A-G5-230
8466,20-05-2024,kasoa,83 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,20-05-2024,20-05-2024,,,0,OPD,
8473,20-05-2024,"SCC
RED TOP",53 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ]",TRADER,,20-05-2024,20-05-2024,,,0,OPD,
8475,20-05-2024,kasoa,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 0 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",TRADER,,20-05-2024,20-05-2024,,,15,OPD,
8534,20-05-2024,MALLAM-BOLA RD,45 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,20-05-2024,20-05-2024,,,0,OPD,
8711,20-05-2024,"gbawe
",71 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,20-05-2024,20-05-2024,,,0,OPD,
8798,20-05-2024,KWASHIEMAN SCHOOL PARK,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,Pensioner,,20-05-2024,20-05-2024,,,60,OPD,
9030,20-05-2024,KASOA,81 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",TRADER,,20-05-2024,20-05-2024,,,50,OPD,
9164,20-05-2024,GBAWE - ,51 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",TRADER,,20-05-2024,20-05-2024,,,145,OPD,
9170,20-05-2024,ABLEKUMA-ANYAA,70 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 14 Days  ], LABETALOL INJECTION 100MG[ LABETALOL | 5MG/ML 20ML | Injection | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Today |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | BDS |  For 1 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LABETALOL INJECTION 100MG[ LABETALOL | 5MG/ML 20ML | Injection ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",Unemployed,,20-05-2024,20-05-2024,,,115,OPD,
9176,19-05-2024,MCCARTH HILL-MENSKROM,47 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,,,BUSINESS PERSON,,19-05-2024,19-05-2024,,,95,OPD,
9395,18-05-2024,"TUBA , KAKRABA",52 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ]","INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",TRADER,,18-05-2024,18-05-2024,,,125,OPD,
9614,18-05-2024,KASOA IRON CITY,65 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"L03.9 [Cellulitis, unspecified]  ==> NEW",No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | BDS |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ]",TRADER,,18-05-2024,18-05-2024,,,210,OPD,
9646,17-05-2024,GBAWE CP,51 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B07.0 [Plantar wart]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], SALICYLIC ACID OINTMENT 2%[ SALICYLIC ACID | 2% 40G | Ointment | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], SALICYLIC ACID OINTMENT 2%[ SALICYLIC ACID | 2% 40G | Ointment ]",TRADER,,17-05-2024,17-05-2024,,,0,OPD,
9692,17-05-2024,SCC WEST MALL OPP,67 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"L03.90 [Cellulitis, unspecified]  ==> NEW",No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], ENOXAPARIN SODIUM INJECTION 40MG[ LOMOH | 40MG/0.4ML | Injection | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | OD |  For 1 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], ENOXAPARIN SODIUM INJECTION 40MG[ LOMOH | 40MG/0.4ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",Unemployed,,17-05-2024,17-05-2024,,,85,OPD,
9717,17-05-2024,mallam bola raod,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ]","METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,17-05-2024,17-05-2024,,,10,OPD,
9721,17-05-2024,oblogo,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-05-2024,17-05-2024,,,10,OPD,
9760,17-05-2024,agape,79 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,17-05-2024,17-05-2024,,,0,OPD,
9891,17-05-2024,WEIJA ROMAN SCH OPPOSITE,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ], INDAPAMIDE SR [ Natrilix | 1.5MG | Tablet | Daily |  For 60 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INDAPAMIDE SR [ Natrilix | 1.5MG | Tablet ]",none,,17-05-2024,17-05-2024,,,10,OPD,
10002,17-05-2024,BORTIANOR,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,17-05-2024,17-05-2024,,,0,OPD,
10005,17-05-2024,"WEIJA 
OBLOGO",65 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,17-05-2024,17-05-2024,,,0,OPD,
10072,17-05-2024,WEIJA WATER WORKS,60 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,A54.5 [Gonococcal pharyngitis]  ==> NEW,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], TRAMADOL INJECTION 100MG[ TRAMADOL | 100MG/2ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 1 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], TRAMADOL INJECTION 100MG[ TRAMADOL | 100MG/2ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",caterer,,17-05-2024,17-05-2024,,,105,OPD,
10169,17-05-2024,SCC,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.49 [Diabetes mellitus due to underlying condition with other diabetic neurological complication]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-05-2024,17-05-2024,,,15,OPD,
10329,17-05-2024,ABLEKUMAN FUNMILK,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"A41.4 [Sepsis due to anaerobes]  ==> NEW, R52.0 [Acute pain]  ==> NEW",No,Non-Insured,"AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 7 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LIDOCAINE INJECTION 2%[ LIDOCAINE |   2% 20ML | Injection | Stat |  For 1 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 30ML[ DREZ  | 30ML | Solution | Stat |  For 1 Days  ]","AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LIDOCAINE INJECTION 2%[ LIDOCAINE |   2% 20ML | Injection ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 30ML[ DREZ  | 30ML | Solution ]",TRADER,,17-05-2024,17-05-2024,,,60,OPD,
10501,16-05-2024,"OLD BARRIER
MANDELA",49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-05-2024,16-05-2024,,,10,OPD,
10505,16-05-2024,scc red top,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], MELATONIN[ RESTWELL | 6MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-05-2024,16-05-2024,,,0,OPD,
10506,16-05-2024,kasoa,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ]",,,16-05-2024,16-05-2024,,,10,OPD,
10509,16-05-2024,MALLAM,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-05-2024,16-05-2024,,,10,OPD,
10563,16-05-2024,SANTA MARIA,72 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.22 [Type 2 diabetes mellitus with diabetic chronic kidney disease]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], LISINOPRIL TABLET 2.5MG[ LISINOPRIL | 2.5MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 2.5MG[ LISINOPRIL | 2.5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",Pensioner,,16-05-2024,16-05-2024,,,10,OPD,
10648,16-05-2024,DARKUMA,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,16-05-2024,16-05-2024,,,0,OPD,
10653,16-05-2024,MALLAM JUNC,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-05-2024,16-05-2024,,,0,OPD,
10661,16-05-2024,new gbawe,83 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ]",,,16-05-2024,16-05-2024,,,0,OPD,
10663,16-05-2024,SCC- MASALACHI,39 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],BUSINESS PERSON,,16-05-2024,16-05-2024,,,15,OPD,
10667,16-05-2024,ABLEKUMA JOMA,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,16-05-2024,16-05-2024,,,10,OPD,
10698,16-05-2024,awoshie,86 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ]",,,16-05-2024,16-05-2024,,,10,OPD,
10730,16-05-2024,TETEGU,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Non-Insured,,,TRADER,,16-05-2024,16-05-2024,,,50,OPD,
11049,16-05-2024,Awoshie ,37 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,Yes,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,16-05-2024,16-05-2024,,,70,OPD,
11098,16-05-2024,SOWUTUOM MARKET,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily AC |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  | BDS |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ANTIOXIDANTS/LYCOPENE/AMINO ACIDS/DHA/ALPHA LIPOIC[ SIDME PRO |  |  ]",Unemployed,,16-05-2024,16-05-2024,,,0,OPD,
11146,16-05-2024,AWOSHIE ANYAA PALACE TOWN,49 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> NEW,,No,Non-Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet | OD |  For 15 Days  ]",,,,16-05-2024,16-05-2024,,,70,OPD,
11241,16-05-2024,"GBAWE, ZERO",61 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,"E10.37X2 [Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye]  ==> OLD",,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | PRN |  For 7 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],businessman,,16-05-2024,16-05-2024,,,0,OPD,
11310,15-05-2024,KWASHIEMAN CHRIST MISSION,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 14 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ]",TRADER,,15-05-2024,15-05-2024,,,60,OPD,
11365,15-05-2024,SCC- MASALACHI,39 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,BUSINESS PERSON,,15-05-2024,15-05-2024,,,50,OPD,
11383,15-05-2024,nurses quarters,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,15-05-2024,15-05-2024,,,50,OPD,
11413,15-05-2024,"TAIFA, NORWAY",68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]",,,,15-05-2024,15-05-2024,,,60,OPD,
11416,15-05-2024,gbawe  top base,77 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BDS |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]",,,,15-05-2024,15-05-2024,,,50,OPD,
11434,15-05-2024,TUBA AGROW FARM,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I16.0 [Hypertensive urgency]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,15-05-2024,15-05-2024,,,35,OPD,
11523,15-05-2024,WEIJA TETEH,49 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,,,,,15-05-2024,15-05-2024,,,60,OPD,
11567,15-05-2024,"AMANFRO 
PEACE TOWN",73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 90 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ]",,,15-05-2024,15-05-2024,,,50,OPD,
11582,15-05-2024,kwashieman,84 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], COLLAGEN/HYAURONATE/GINKGO BILOBA/MSM/OMEGA-3/VITAMINS[ SDILEGE ADVANCE |  | Tablet ]",,,15-05-2024,15-05-2024,,,50,OPD,
11587,15-05-2024,gbawe,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 1 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,15-05-2024,15-05-2024,,,60,OPD,
11597,15-05-2024,Awoshie,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Stat |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,15-05-2024,15-05-2024,,,60,OPD,
11627,15-05-2024,NEW WEIJA,46 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,"I15.9 [Secondary hypertension, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,15-05-2024,15-05-2024,,,60,OPD,
11671,15-05-2024,GBAWE  -ZERO,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,AGED,,15-05-2024,15-05-2024,,,65,OPD,
11882,15-05-2024,WEIJA APLAKU,65 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,,,BUSINESS PERSON,,15-05-2024,15-05-2024,,,0,OPD,
12161,14-05-2024,KWAHU NSABAH,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,14-05-2024,14-05-2024,,,60,OPD,
12163,14-05-2024,"AWOSHIE
A LANE",56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TID |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",caterer,,14-05-2024,14-05-2024,,,60,OPD,
12168,14-05-2024,"WEIJA 
PRESBY PRIMARY",57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 60 Days  ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule | OD |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule ]",,,14-05-2024,14-05-2024,,,50,OPD,
12169,14-05-2024,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]",,,,14-05-2024,14-05-2024,,,60,OPD,
12171,14-05-2024,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]",,,,14-05-2024,14-05-2024,,,50,OPD,
12174,14-05-2024,kasoa,55 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 10 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,14-05-2024,14-05-2024,,,50,OPD,
12179,14-05-2024,apleku,53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]",,,,14-05-2024,14-05-2024,,,60,OPD,
12181,14-05-2024,POKUASE,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | BDS |  For 60 Days  ]",,,,14-05-2024,14-05-2024,,,50,OPD,
12182,14-05-2024,kasoa,32 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],,,,14-05-2024,14-05-2024,,,60,OPD,
12314,14-05-2024,WEIJA,82 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",Retired,,14-05-2024,14-05-2024,,,60,OPD,
12392,14-05-2024,AMANFROM - GALILIA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,TRADER,,14-05-2024,14-05-2024,,,60,OPD,
12555,14-05-2024,NEW BORTIANO,42 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,14-05-2024,14-05-2024,,,50,OPD,
12911,13-05-2024,gbawe zero,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BID |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,13-05-2024,13-05-2024,,,10,OPD,
12914,13-05-2024,ABLEKUMA,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ]",pension,,13-05-2024,13-05-2024,,,15,OPD,
12922,13-05-2024,ABLEKUAMH-NIC,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,13-05-2024,13-05-2024,,,10,OPD,
12926,13-05-2024,"MALLAM
KOKROKO",45 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,13-05-2024,13-05-2024,,,65,OPD,
12932,13-05-2024,bulemi top,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 60 Days  ]",,,,13-05-2024,13-05-2024,,,10,OPD,
12980,13-05-2024,WEIJA POLICE STATION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",driver,,13-05-2024,13-05-2024,,,10,OPD,
12989,13-05-2024,GBAWE ZERO,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,13-05-2024,13-05-2024,,,0,OPD,
13005,13-05-2024,WEIJA,79 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,13-05-2024,13-05-2024,,,10,OPD,
13023,13-05-2024,AMASAMAN OKPA,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ]",,DRIVER,,13-05-2024,13-05-2024,,,65,OPD,
13039,13-05-2024,"A-LANG
",62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,Pensioner,,13-05-2024,13-05-2024,,,20,OPD,
13078,13-05-2024,"ODORKOR , GLORY LAND",65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-05-2024,13-05-2024,,,0,OPD,
13086,13-05-2024,"SCC , DUNKUNA ",68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,13-05-2024,13-05-2024,,,0,OPD,
13096,13-05-2024,WEIJA ,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",TRADER,,13-05-2024,13-05-2024,,,0,OPD,
13134,13-05-2024,AWOSHIE,29 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,N13.30 [Unspecified hydronephrosis]  ==> OLD,Yes,Insured,"PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 0 Days  ], INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 0 Days  ]",,,,13-05-2024,13-05-2024,,,55,OPD,
13143,13-05-2024,NEW WEIJA,46 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,EARLY LENS CHANGES ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,13-05-2024,13-05-2024,,,0,OPD,
13306,13-05-2024,"GBAWE , TOP BASE",46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | Daily |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",CLEGY,,13-05-2024,13-05-2024,,,0,OPD,
13315,13-05-2024,"KASOA
OPEIKUMA",54 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,"R11.10 [Vomiting, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ]",BANKER,,13-05-2024,13-05-2024,,,70,OPD,
13661,13-05-2024,WEIJA MODEX,61 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ]",TRADER,,13-05-2024,13-05-2024,,,125,OPD,
13927,11-05-2024,SAKAMAN TANTUAH SCH,55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> RECURRING,"A01.0 [Typhoid fever]  ==> NEW, N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 10 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 5 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",FOOD SELLER,,11-05-2024,11-05-2024,,,10,OPD,
14190,10-05-2024,ABLEKUMA NIC ,62 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"A41.9 [Sepsis, unspecified]  ==> NEW, J30.4 [Allergic rhinitis, unspecified]  ==> OLD",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], L-MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet | Daily |  For 10 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], L-MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet ]",,,10-05-2024,10-05-2024,,,10,OPD,
14197,10-05-2024,odorkor,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,10-05-2024,10-05-2024,,,10,OPD,
14200,10-05-2024,GBAWE ZERO,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ],AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ],,,10-05-2024,10-05-2024,,,10,OPD,
14278,10-05-2024,KASOA BARRIER,86 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,10-05-2024,10-05-2024,,,10,OPD,
14544,10-05-2024,SWOTUM,86 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,10-05-2024,10-05-2024,,,10,OPD,
14599,10-05-2024,"WEIJA
MANDELA",49 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B1+B2+B6+B12+GLUTAMIC ACID[ NEURO-MIN PLUS |  | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,10-05-2024,10-05-2024,,,0,OPD,
14644,10-05-2024,mantaheko,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,,,10-05-2024,10-05-2024,,,0,OPD,
14789,10-05-2024,"KASOA , NYANYANO ",84 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-05-2024,10-05-2024,,,0,OPD,1663/17 MR-6B-E6-38
15028,09-05-2024,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,09-05-2024,09-05-2024,,,0,OPD,
15029,09-05-2024,oblogo,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,09-05-2024,09-05-2024,,,10,OPD,
15033,09-05-2024,"DARKUMAN
MASALAKYI",60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 7 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | BDS |  For 7 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TDS |  For 5 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ]",,,09-05-2024,09-05-2024,,,0,OPD,
15034,09-05-2024,mallam bola road ,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,09-05-2024,09-05-2024,,,0,OPD,
15038,09-05-2024,ANYAA,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,09-05-2024,09-05-2024,,,0,OPD,
15055,09-05-2024,mccarthy,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,09-05-2024,09-05-2024,,,50,OPD,
15058,09-05-2024,CHOICE,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,09-05-2024,09-05-2024,,,0,OPD,
15060,09-05-2024,"SANTA MARIA
NSUFA",39 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",TRADER,,09-05-2024,09-05-2024,,,15,OPD,
15065,09-05-2024,mallam,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]",,,,09-05-2024,09-05-2024,,,10,OPD,
15091,09-05-2024,weija,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,09-05-2024,09-05-2024,,,10,OPD,
15144,09-05-2024,AMASAMAN OKPA,56 Year(s),Male,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,,,DRIVER,,09-05-2024,09-05-2024,,,130,OPD,
15347,09-05-2024,weija,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]",,,,09-05-2024,09-05-2024,,,10,OPD,
15348,09-05-2024,GBAWE,81 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 0 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TDS |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ]",,,09-05-2024,09-05-2024,,,0,OPD,
15382,09-05-2024,JOHN TEYE,61 Year(s),Female,WELLNESS CLINIC,General Consultation ,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,G60.3 [Idiopathic progressive neuropathy]  ==> OLD,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BID |  For 7 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,09-05-2024,09-05-2024,,,10,OPD,
15505,09-05-2024,"NYANYANO
MILLINIUM CITY",69 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Non-Insured,"CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]",,Pensioner,,09-05-2024,09-05-2024,,,80,OPD,
15522,09-05-2024,KASOA,70 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,09-05-2024,09-05-2024,,,50,OPD,
15775,09-05-2024,AWOSHIE - AYAA,66 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 7 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Retired,,09-05-2024,09-05-2024,,,245,OPD,
16005,08-05-2024,ODORKOR. GLORYLAND,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,08-05-2024,08-05-2024,,,10,OPD,
16021,08-05-2024,ANYAA-PALAS TOWN,65 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,08-05-2024,08-05-2024,,,50,OPD,23719/20
16026,08-05-2024,KASOA,55 Year(s),Female,DIETERAPY,General Consultation Child,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,08-05-2024,08-05-2024,,,50,OPD,MR-7A-F5-118
16056,08-05-2024,kasoa,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,08-05-2024,08-05-2024,,,10,OPD,
16226,08-05-2024,new bortianor,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TDS |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | Daily |  For 30 Days  ]",,,,08-05-2024,08-05-2024,,,0,OPD,
16514,08-05-2024,SOWUTUOM,81 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | q8h |  For 7 Days  ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet | OD |  For 30 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet ]",,,08-05-2024,08-05-2024,,,0,OPD,
16515,08-05-2024,GBAWE-ZERO,38 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",TRADER,,08-05-2024,08-05-2024,,,60,OPD,
16603,08-05-2024,NEW  APLAKU WEST HILLS,57 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,"LIDOCAINE INJECTION 2%[ LIDOCAINE |   2% 20ML | Injection | Daily |  For 1 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 100ML[ DREZ  | 100ML | Solution | Daily |  For 1 Days  ]",,TRADER,,08-05-2024,08-05-2024,,,95,OPD,
16736,07-05-2024,WEIJA TETEH,49 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,07-05-2024,07-05-2024,,,10,OPD,
16738,07-05-2024,kasoa,59 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], FLUCLOXACILLIN+AMOXICILLIN[ FLUXAMOX | 500MG | Capsule | QID |  For 7 Days  ], DEEP FREEZE SPRAY[ DEEP FREEZE SPRAY |  | Spray | BDS |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FLUCLOXACILLIN+AMOXICILLIN[ FLUXAMOX | 500MG | Capsule ], DEEP FREEZE SPRAY[ DEEP FREEZE SPRAY |  | Spray ]",,,07-05-2024,07-05-2024,,,15,OPD,
16777,07-05-2024,KASOA OFAAKOR,74 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | BDS |  For 60 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,07-05-2024,07-05-2024,,,60,OPD,
16780,07-05-2024,PIG FARM,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,07-05-2024,07-05-2024,,,0,OPD,
16781,07-05-2024,weija,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TDS |  For 5 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | BDS |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,07-05-2024,07-05-2024,,,10,OPD,
16782,07-05-2024,MALLAM,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-05-2024,07-05-2024,,,10,OPD,
16790,07-05-2024,SCC  -AZUMA  DAM  SIDE,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | TID |  For 5 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ]",Pensioner,,07-05-2024,07-05-2024,,,10,OPD,
16791,07-05-2024,MALLAM-POLICE,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,07-05-2024,07-05-2024,,,10,OPD,20137/19
16795,07-05-2024,weija ,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",,,07-05-2024,07-05-2024,,,10,OPD,
16797,07-05-2024,"GBAWE
TOP BASE",56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",seamstress,,07-05-2024,07-05-2024,,,10,OPD,
16799,07-05-2024,ABLEKUMA ,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,07-05-2024,07-05-2024,,,0,OPD,
16842,07-05-2024,GBAWE-BULEMI,83 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-05-2024,07-05-2024,,,10,OPD,4397/20
16845,07-05-2024,GBAWE ZERO,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 5 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ]","DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",,,07-05-2024,07-05-2024,,,10,OPD,
16850,07-05-2024,gbawe,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 0 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 0 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | Daily |  For 5 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,07-05-2024,07-05-2024,,,0,OPD,
17180,07-05-2024,GBAWE,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension | BID |  For 5 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | BDS |  For 5 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],  (NUGEL  O) ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETA[ NUGEL - O  | 200ML | Suspension ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ]",,,07-05-2024,07-05-2024,,,10,OPD,
17192,07-05-2024,DARKUMA,56 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-05-2024,07-05-2024,,,0,OPD,
17211,07-05-2024,NEW FADAMA NEAR NCHIEF IMAN,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ]",AGED,,07-05-2024,07-05-2024,,,10,OPD,
17364,07-05-2024,KASOA KUWAIT,47 Year(s),Female,EYE CLINIC ,Review Consultation Adult ,,No Outcome,NA ,"E08.3299 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye]  ==> NEW",,No,Non-Insured,,,seamstress,,07-05-2024,07-05-2024,,,0,OPD,
17435,07-05-2024,weija new twon,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-05-2024,07-05-2024,,,0,OPD,
17628,07-05-2024,ABLEKUMA -ODUMA,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Insured,"CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",Unemployed,,07-05-2024,07-05-2024,,,65,OPD,
17636,07-05-2024,WAJIA GBAWE,35 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ]",,,07-05-2024,07-05-2024,,,145,OPD,
17692,06-05-2024,ODORKOR,40 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,06-05-2024,06-05-2024,,,0,OPD,
17783,06-05-2024,SANTA MARIA AUNTIE AKU,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> OLD,,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], CARVEDILOL 25MG[  |  |  | OD |  For 60 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Nocte |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CARVEDILOL 25MG[  |  |  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",,,06-05-2024,06-05-2024,,,10,OPD,
17790,06-05-2024,malam,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,06-05-2024,06-05-2024,,,0,OPD,
17791,06-05-2024,KASOA KABULEY JUNCTION,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,06-05-2024,06-05-2024,,,10,OPD,
17795,06-05-2024,ODORKOR,58 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,06-05-2024,06-05-2024,,,10,OPD,
17796,06-05-2024,galilea,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,06-05-2024,06-05-2024,,,10,OPD,
17802,06-05-2024,KASOA,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,06-05-2024,06-05-2024,,,10,OPD,
17831,06-05-2024,WEIJA APLAKU,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MELATONIN[ RESTWELL | 6MG | Tablet ]",,,06-05-2024,06-05-2024,,,50,OPD,
17836,06-05-2024,weija,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,06-05-2024,06-05-2024,,,10,OPD,
17839,06-05-2024,KASOA BROADCASTING,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet ]",TRADER,,06-05-2024,06-05-2024,,,10,OPD,
17955,06-05-2024,TUBA,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Nocte |  For 5 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",pension,,06-05-2024,06-05-2024,,,0,OPD,
18266,06-05-2024,malam,65 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,06-05-2024,06-05-2024,,,50,OPD,
18334,06-05-2024,ABLEKUMA  -MAAME  NKRAN,34 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,,,Unemployed,,06-05-2024,06-05-2024,,,10,OPD,
18360,06-05-2024,AMANFROM NASEC,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"G62.9 [Polyneuropathy, unspecified]  ==> NEW, A01.0 [Typhoid fever]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",FOOD VENDOR,,06-05-2024,06-05-2024,,,0,OPD,
18618,05-05-2024,NEW WEIJA,46 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"K29.1 [Other acute gastritis]  ==> NEW, I10.00 [Essential (primary) hypertension]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW, N39.0 [Urinary tract infection, site not specified]  ==> NEW, A01.0 [Typhoid fever]  ==> NEW",No,Insured,"OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 15 Days  ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection | TDS |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Today |  For 1 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | TDS |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | BDS |  For 1 Days  ]","OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ]",TRADER,,05-05-2024,05-05-2024,,,65,OPD,
18689,05-05-2024,WEIJA-SCC,43 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,05-05-2024,05-05-2024,,,65,OPD,
19139,03-05-2024,"SCC
TIE TOP",51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,03-05-2024,03-05-2024,,,10,OPD,
19141,03-05-2024,AGAPE 2ND CONTAINER,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 14 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,03-05-2024,03-05-2024,,,0,OPD,
19153,03-05-2024,dansoman,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,03-05-2024,03-05-2024,,,0,OPD,
19163,03-05-2024,AMANFROM NASEC,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,FOOD VENDOR,,03-05-2024,03-05-2024,,,10,OPD,
19206,03-05-2024,WEIJA-SCH JUNCTION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,03-05-2024,03-05-2024,,,10,OPD,
19211,03-05-2024,BUBUASHIE,90 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 14 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,03-05-2024,03-05-2024,,,0,OPD,
19255,03-05-2024,AWOSHIE,59 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,03-05-2024,03-05-2024,,,60,OPD,
19595,03-05-2024,SCC- MASALACHI,39 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | OD |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",BUSINESS PERSON,,03-05-2024,03-05-2024,,,65,OPD,
19626,03-05-2024,kasao,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,03-05-2024,03-05-2024,,,15,OPD,
19966,02-05-2024,upper weija,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-05-2024,02-05-2024,,,15,OPD,
19974,02-05-2024,AYIGBE TOWN,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,02-05-2024,02-05-2024,,,10,OPD,
19981,02-05-2024,bubiashie,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-05-2024,02-05-2024,,,0,OPD,
20004,02-05-2024,"GBAWE , CP",76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 14 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 14 Days  ]",,,,02-05-2024,02-05-2024,,,10,OPD,
20127,02-05-2024,KWASHIEMAN,57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-05-2024,02-05-2024,,,0,OPD,
20376,02-05-2024,"NEW BORTIANOR , LAS VEGAS ",69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,02-05-2024,02-05-2024,,,15,OPD,
20429,02-05-2024,WEIJA KOKOBEN,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,,,02-05-2024,02-05-2024,,,0,OPD,
20443,02-05-2024,AUNTIE AKU PRESBY ,62 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,driver,,02-05-2024,02-05-2024,,,50,OPD,
20686,02-05-2024,BORTIANOR,38 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.01 [Diabetes mellitus due to underlying condition with hyperosmolarity with coma]  ==> OLD,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,02-05-2024,02-05-2024,,,50,OPD,
21008,01-05-2024,ODORKOR GLORY LAND,72 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.10 [Type 2 diabetes mellitus with ketoacidosis without coma]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BDS |  For 3 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",HEADMISTRESS,,01-05-2024,01-05-2024,,,115,OPD,
